Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-06-14
2011-06-14
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S287000
Reexamination Certificate
active
07960399
ABSTRACT:
The present invention relates to the use of a quinazolinone compound of the formula (I) wherein R1, R2, R3, R4, R5and m are as defined in the specification and in the claims, in free form or in salt form, and, where possible, in acid addition salt form, as a vanilloid.
REFERENCES:
patent: 2749344 (1956-06-01), Hitchings et al.
patent: 3317388 (1967-05-01), Shetty et al.
patent: 3793326 (1974-02-01), Muren
patent: 3864362 (1975-02-01), Feuer et al.
patent: 4501755 (1985-02-01), Wu
patent: 4841076 (1989-06-01), Kitagawa et al.
patent: 4841077 (1989-06-01), Ito et al.
patent: 5284853 (1994-02-01), Levin et al.
patent: 5294617 (1994-03-01), Venkatesan et al.
patent: 5830909 (1998-11-01), Crandall
patent: 5948775 (1999-09-01), Koko et al.
patent: 5958930 (1999-09-01), Gangjee
patent: 6335180 (2002-01-01), Julius et al.
patent: 6476076 (2002-11-01), Lee et al.
patent: 6500853 (2002-12-01), Seehra et al.
patent: 6723730 (2004-04-01), Bakthavatchalam et al.
patent: 6790629 (2004-09-01), Julius et al.
patent: 7097991 (2006-08-01), Julius et al.
patent: 2003/0049728 (2003-03-01), Julius et al.
patent: 2003/0158198 (2003-08-01), Lee et al.
patent: 2003/0220227 (2003-11-01), Gungor et al.
patent: 2004/0138454 (2004-07-01), Culshaw et al.
patent: 2005/0095650 (2005-05-01), Julius et al.
patent: 2005/0182045 (2005-08-01), Nagase et al.
patent: 2006/0154942 (2006-07-01), Culshaw et al.
patent: 2008/0114056 (2008-05-01), Ritchie et al.
patent: 2008/0293939 (2008-11-01), Culshaw et al.
patent: 2009/0082365 (2009-03-01), Bhalay et al.
patent: 2010/0144740 (2010-06-01), Fox et al.
patent: 2010/0197705 (2010-08-01), Chen et al.
patent: 239090 (1906-11-01), None
patent: 1 232 152 (1967-01-01), None
patent: 1 047 711 (2003-08-01), None
patent: 1 009 804 (2003-10-01), None
patent: 1 398 032 (2004-03-01), None
patent: 1 600 440 (2005-11-01), None
patent: 1367738 (1964-06-01), None
patent: 1412615 (1965-10-01), None
patent: 2 167 642 (1973-08-01), None
patent: 936902 (1963-09-01), None
patent: 1003802 (1965-09-01), None
patent: 1076747 (1967-07-01), None
patent: 1 495 305 (1977-12-01), None
patent: 62-193605 (1987-08-01), None
patent: 7-258224 (1995-10-01), None
patent: 10-259176 (1998-01-01), None
patent: 1 262 927 (1997-11-01), None
patent: WO 92/013535 (1992-08-01), None
patent: WO 95/03293 (1995-02-01), None
patent: WO 95/18616 (1995-07-01), None
patent: WO 97/28118 (1997-08-01), None
patent: WO 97/44041 (1997-11-01), None
patent: WO 98/02162 (1998-01-01), None
patent: WO 98/11438 (1998-03-01), None
patent: WO 98/18781 (1998-05-01), None
patent: WO 98/29403 (1998-07-01), None
patent: WO 99/09140 (1999-02-01), None
patent: WO 99/43654 (1999-09-01), None
patent: WO 01/17985 (2001-03-01), None
patent: WO 01/70228 (2001-09-01), None
patent: WO 02/08221 (2002-01-01), None
patent: WO 02/28851 (2002-04-01), None
patent: WO 02/083143 (2002-10-01), None
patent: WO 2002/076946 (2002-10-01), None
patent: 03/014064 (2003-02-01), None
patent: 03/048132 (2003-06-01), None
patent: WO 03/106435 (2003-12-01), None
patent: 2004/005265 (2004-01-01), None
patent: WO 2004/033435 (2004-04-01), None
patent: WO 2004/041755 (2004-05-01), None
patent: WO 2004/072051 (2004-08-01), None
patent: WO 2005/023782 (2005-03-01), None
patent: WO 2005/040112 (2005-05-01), None
patent: WO 2005/049613 (2005-06-01), None
patent: WO 2005/120510 (2005-12-01), None
patent: WO 2005/121116 (2005-12-01), None
patent: WO 2006/122200 (2006-11-01), None
patent: WO 2010/084050 (2010-07-01), None
Jordan, V. C. Nature Reviews: Drug Discovery, 2, 2003, p. 205.
DörwaId, F. Zaragoza. Side Reactions in Organic Synthesis: A Guide to Successful Synthesis Design, Weinheim: WILEY-VCH Verlag GmbH & Co. KGaA, 2005, Preface.
Wolff, Manfred E., Ed. Burger's Medicinal Chemistry and Drug Discovery—Fifth Edition, New York: John Wiley & Sons, 1996, vol. 1, pp. 975-976.
E.B. Pedersen, “Phosphorammides: III. Phenyl N,N-Dimethylphosphorodiamidate as a New Reagent for the Synthesis of 3-Methyl-4-oxo-3,4-dihydroquinazolines”, Communications Synthesis (1977), XP-002453882, pp. 180-181.
B.P. Joshi et al,, “Studies in Quinazolones: Part I—Synthesis & Spectral Characteristics of Substituted 2-Isopropyl-4(3H)-quinazolones”, Indian Journal of Chemistry, vol. 16B (1978), pp. 1067-1072.
S. K. P. Sinha et al., “Quinazolones: Part XI—Effect of Substituents on Claisen Rearrangement of Allyloxyquinazolones”, Indian Journal of Chemistry, vol. 24B (1985), pp. 1182-1184.
Restriction Requirement issued in U.S. Appl. No. 12/095,995, Mailed Sep. 28, 2009.
William Martindale, “Extra Pharmacopoeia”, 25th edition, The Pharmaceutical Press, pp. 1453-1467, 1967 (BM 1).
The Merck Index, 11th edition, Merck & Co, p. 2107 (1989) (BM 6).
William Martindale, “The Extra Pharmacopoeia”, 31st edition, Royal Pharmaceutical Society, pp. 686-687 (1996) (BM 7).
The Merck Index, 11th edition, Merck & Co, p. 1848 (1989) (BM 5).
Goodman and Gilman's, “The Pharmacological Basis of Therapeutics”, 7th edition, Macmillan Publishing, p. 1807 and p. 1827 (1985) (BM 4).
William Martindale, “The Extra Pharmacopoeia”, 31st edition, Royal Pharmaceutical Society, p. xi (1996) (BM 3).
William Martindale, “The Extra Pharmacopoeia”, 31st edition, Royal Pharmaceutical Society, p. 1511 (1996) (BM 2).
“Diazonium-Verbindungen”, Roempp Chemie Lexikon, Version 1.0, Thieme Verlag 1995 (E 8), English transl.
Merck Safety Data Sheet:, Acetic Acid (Last Revision Feb. 22, 2002) (E 7), English transl.
J. March, “Advanced Organic Chemistry”, 4th edition, Wiley, p. 1216, 1992 (E 6).
Daenens et al., “Biotransformation of Mecloqualone in Man”, Arzneimittel-Forschung, vol. 24, No. 2 (1974), pp. 195-202 + Abstract.
Ericsonn et al., “Methaqualone metabolites”, Acta Pharmaceutica Suecica, vol. 10, No. 4 (1973), pp. 257-262 + Abstract.
Breuer et al., “Beziehungen zwischen chemischer Konstitution und pharmakologischer Wirkung bei aminosubstituierten 3-Aryl-4(3H)-chinazolinonen”, Arzneimittel-Forschung, vol. 21, No. 2 (1971) pp. 238-243 + Abstract.
Somasekhara et al., “Some new derivatives of 3, 4-dihydroquinazolin-4-one of pharmacological interest”, The Indian Journal of Pharmacy, vol. 27, No. 1 (1965), pp. 12-13 + Abstract.
Taylor Boger et al., “Researches on Quinazolines (Twenty-seventh Paper). The Synthesis of 3-Aminoary1-4-Quinozolones From Acylathranils and Aromatic Diamines.” Contribution from the Havemeyer Laboratories of Columbia University No. 190, XP-002453809, pp. 949-962, (1911).
Marston Taylor Bogert et al., “Researches on Quinazolines (Twenty-Third Paper). On 6-Methyl-7-Aminoguinazolones, 7-Nitroquinazolone-6-Carboxylic Acids, and 1,3,7,9-Naphthotetrazines.” Contribution from the Haverneyer Laboratories of Columbia University No. 169, XP-002453810, pp. 1071-1078, (1909).
English translation of Japanese Office Action dated May 18, 2010, 2 pgs.
Gurdip Bhalay, U.S. PTO Office Action, U.S. Appl. No. 12/095,995, Mar. 29, 2010, 11 pgs.
Chemical Abstracts, “3-Phenylquinazolones”, Olin Mathieson Chemical Corp., vol. 62 (1965), 1672a-e, 1 pg.
Parikh et al., “Some Pharmacological Studies on 2-Methyl-3-(3,5-dimethyl-4-hydroxyphenyl)-3,4-dihydroquinazolin-4-one (SRC-226) and its Derivatives”, The Indian Journal of Pharmacy, vol. 38, No. 3 (1976), pp. 89-90.
Shetty et al, “6-Aminoquinazolinones as Potent Analgetic Agents”, CNS (Cent. Nerv. Syst.) Drugs, Symp. (1966), pp. 156-69, Publisher: Council of Scientific & Industrial Research, New Delhi, India.
Somasekhara et al., “3-Aryl-2-isoPropyl and 2-Aryl-3-isoPropyl Derivatives of 4-(3H)-Quinazolinones”, The Indian Journal of Pharmacy, vol. 33, No. 1 (1971), pp. 26-27.
Kacker et al., “Potential Analgesics. Part I. Synthesis of Substituted 4-Quinazolones”, Journal of the Indian Chemical Society, vol. 28 (1951), pp. 344-346.
Al-Maharik et al., ȁ
Novartis AG
Strain Paul D.
Strain & Strain PLLC
Willis Douglas M
Wilson James O
LandOfFree
Quinazolinone derivatives useful as vanilloid antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazolinone derivatives useful as vanilloid antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazolinone derivatives useful as vanilloid antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2742714